ALBANY, N.Y.--(BUSINESS WIRE)--Dec. 1, 2005--Albany Molecular Research, Inc. (Nasdaq: AMRI) announced today that Steven R. Hagen, Ph.D. has joined the company as senior director of analytical quality services. In his new role, Dr. Hagen will oversee all analytical chemistry efforts, which includes providing support for early stage discovery and preclinical development, as well as the manufacturing of clinical trial materials, intermediates, and commercial active pharmaceutical ingredients. This includes developing analytical methods to test the purity of clinical trial candidates and commercial products manufactured at AMRI. He will provide leadership to a team of over 100 skilled analytical chemists and work closely with customers.
